title: Are direct oral anticoagulants such as edoxaban safer than heparin or vitamin K-antagonists when intracranial hemorrhage occurs?
authors.affiliation: IMD Coagulation Center Mannheim, 68163 Mannheim, Germany.
authors.forename: Carl-Erik Hartmut
authors.initials: CE
authors.lastname: Dempfle
mesh_terms: D000284:Administration, Oral; D000818:Animals; D000925:Anticoagulants / Q000009:adverse effects* / Q000627:therapeutic use; D006493:Heparin / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D020300:Intracranial Hemorrhages / Q000139:chemically induced*; D011725:Pyridines / Q000009:adverse effects* / Q000627:therapeutic use; D051381:Rats; D013844:Thiazoles / Q000009:adverse effects* / Q000627:therapeutic use; D014812:Vitamin K / Q000037:antagonists & inhibitors*
chemical_list: D000925:Anticoagulants; D011725:Pyridines; D013844:Thiazoles; D014812:Vitamin K; D006493:Heparin; C552171:edoxaban